NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 107 filers reported holding NEWLINK GENETICS CORP in Q3 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $838,000 | +78.7% | 331,258 | +12.3% | 0.00% | – |
| Q3 2019 | $469,000 | +61.2% | 294,934 | +50.1% | 0.00% | – |
| Q2 2019 | $291,000 | +519.1% | 196,500 | +715.4% | 0.00% | – |
| Q1 2019 | $47,000 | -52.0% | 24,100 | -62.8% | 0.00% | – |
| Q4 2018 | $98,000 | -3.9% | 64,761 | +52.4% | 0.00% | – |
| Q3 2018 | $102,000 | -96.3% | 42,500 | -92.8% | 0.00% | – |
| Q2 2018 | $2,792,000 | -68.8% | 586,501 | -52.6% | 0.00% | -100.0% |
| Q1 2018 | $8,962,000 | +116.7% | 1,236,101 | +142.4% | 0.00% | +50.0% |
| Q4 2017 | $4,136,000 | +32.1% | 509,962 | +65.8% | 0.00% | +100.0% |
| Q3 2017 | $3,131,000 | +69.1% | 307,581 | +22.1% | 0.00% | 0.0% |
| Q2 2017 | $1,852,000 | -84.9% | 252,000 | -50.4% | 0.00% | -85.7% |
| Q1 2017 | $12,236,000 | +27.7% | 507,700 | -45.5% | 0.01% | +40.0% |
| Q4 2016 | $9,585,000 | -28.0% | 932,396 | +5.2% | 0.01% | -16.7% |
| Q3 2016 | $13,314,000 | +5.0% | 886,431 | -21.3% | 0.01% | -14.3% |
| Q2 2016 | $12,683,000 | -40.5% | 1,126,357 | -3.8% | 0.01% | -36.4% |
| Q1 2016 | $21,318,000 | -43.2% | 1,171,277 | +13.5% | 0.01% | -38.9% |
| Q4 2015 | $37,561,000 | -0.6% | 1,032,190 | -2.1% | 0.02% | +5.9% |
| Q3 2015 | $37,788,000 | -33.4% | 1,054,375 | -17.7% | 0.02% | -29.2% |
| Q2 2015 | $56,749,000 | -44.2% | 1,281,887 | -31.1% | 0.02% | -47.8% |
| Q1 2015 | $101,779,000 | +46.2% | 1,860,326 | +6.2% | 0.05% | +70.4% |
| Q4 2014 | $69,634,000 | +135.8% | 1,751,798 | +27.0% | 0.03% | +145.5% |
| Q3 2014 | $29,535,000 | +18.5% | 1,378,867 | +46.9% | 0.01% | 0.0% |
| Q2 2014 | $24,929,000 | +62.0% | 938,958 | +73.3% | 0.01% | +57.1% |
| Q1 2014 | $15,386,000 | +9.0% | 541,780 | -15.5% | 0.01% | 0.0% |
| Q4 2013 | $14,120,000 | +37.7% | 641,498 | +17.5% | 0.01% | +16.7% |
| Q3 2013 | $10,252,000 | +144.3% | 545,939 | +156.5% | 0.01% | +200.0% |
| Q2 2013 | $4,197,000 | – | 212,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |